Renalytix plc CEO James McCullough's 2024 pay falls 25% to $780K
Renalytix plc reports 2024 executive compensation
By ExecPay News
Published: November 25, 2024
Renalytix plc reported fiscal year 2024 executive compensation information on November 25, 2024.
In 2024, five executives at Renalytix plc received on average a compensation package of $563K, a 27% decrease compared to previous year.
James McCullough, Chief Executive Officer, received $780K in total, which decreased by 25% compared to 2023. 65% of McCullough's compensation, or $510K, was in salary. McCullough also received $242K in option awards and $29K in other compensation.
Thomas McLain, Prior President, received a compensation package of $762K, which increased by 15% compared to previous year. 55% of the compensation package, or $421K, was in salary.
O. James Sterling, Chief Financial Officer, earned $467K in 2024, a 25% decrease compared to previous year.
Fergus Fleming, Chief Technology Officer, received $426K in 2024.
Michael J. Donovan, Chief Medical Officer, earned $380K in 2024.
Renalytix plc's fiscal year ends on June 30.